We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development content piece image
Read time: Less than a minute

Hypha Discovery, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide.

Over the last eight years, Hypha has developed a microbial and mammalian biotransformation platform, for biotransforming drugs and agrochemicals into metabolites and environmental fate derivatives that could not be made using conventional synthetic methods.

It has added to its existing portfolio of services the capability to chemically synthesize glucuronide metabolites using proprietary methods that modify the parent compound. Thus, Hypha is offering a combination of both biological and chemical techniques, i.e. a one-stop offering for all metabolite exploration needs, designed such that clients could quickly establish a method to identify and scale up any type of metabolite.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.